Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.
Published in International journal of antimicrobial agents • Dec 1, 2011
NobleIDNI2P41W69R56S11
Authors:,,
Joop E Arends
Justin H Fransen
Andy I M Hoepelman
Abstract
Host polymorphisms in the IL28B region have recently been associated with outcome of treatment for hepatitis C virus (HCV) infection. This study clearly shows an association between first-phase viral load decrease and the IL28B rs12979860 polymorphism in chronic HCV-infected patients. Furthermore, a...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!